Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 775

1.

Sodium glucose co-transporter 2 inhibitors for glycemic control in type 2 diabetes mellitus: Quality of reporting of randomized controlled trials.

Mittal N, Mittal R, Kumar H, Medhi B.

Perspect Clin Res. 2016 Jan-Mar;7(1):21-7. doi: 10.4103/2229-3485.173777.

2.

Effects of different exercise programs and minimal detectable changes in hemoglobin A1c in patients with type 2 diabetes.

de Lade CG, Marins JC, Lima LM, de Carvalho CJ, Teixeira RB, Albuquerque MR, Reis JS, Amorim PR.

Diabetol Metab Syndr. 2016 Feb 16;8:13. doi: 10.1186/s13098-016-0123-y. eCollection 2016.

3.

Intensive versus conventional glycaemic control for treating diabetic foot ulcers.

Fernando ME, Seneviratne RM, Tan YM, Lazzarini PA, Sangla KS, Cunningham M, Buttner PG, Golledge J.

Cochrane Database Syst Rev. 2016 Jan 13;1:CD010764. doi: 10.1002/14651858.CD010764.pub2. Review.

PMID:
26758576
4.

Clinical characteristics of type 2 diabetic patients on basal insulin therapy with adequate fasting glucose control who do not achieve HbA1c targets.

Mata-Cases M, Mauricio D, Franch-Nadal J.

J Diabetes. 2016 Jan 8. doi: 10.1111/1753-0407.12373. [Epub ahead of print]

PMID:
26749415
5.

HbA1c overtesting and overtreatment among US adults with controlled type 2 diabetes, 2001-13: observational population based study.

McCoy RG, Van Houten HK, Ross JS, Montori VM, Shah ND.

BMJ. 2015 Dec 8;351:h6138. doi: 10.1136/bmj.h6138.

6.

Distal Symmetric Polyneuropathy: A Review.

Callaghan BC, Price RS, Feldman EL.

JAMA. 2015 Nov 24;314(20):2172-81. doi: 10.1001/jama.2015.13611. Review.

PMID:
26599185
7.

Overview of Data Concerning the Safe Use of Antihyperglycemic Medications in Type 2 Diabetes Mellitus and Chronic Kidney Disease.

Roussel R, Lorraine J, Rodriguez A, Salaun-Martin C.

Adv Ther. 2015 Nov;32(11):1029-64. doi: 10.1007/s12325-015-0261-x. Epub 2015 Nov 18.

PMID:
26581749
8.

Dapagliflozin combination therapy in type 2 diabetes mellitus.

Yacoub T.

Postgrad Med. 2016 Jan;128(1):124-36. doi: 10.1080/00325481.2016.1111119. Epub 2015 Nov 16. Review.

PMID:
26571022
9.
10.

Intensifying Insulin Therapy in Type 2 Diabetes: Choices & Challenges.

Kumar A, Kesavadev J, Sethi B, Jain SM, Guruprasad CS, Shah SN.

J Assoc Physicians India. 2015 May;63(5 Suppl):8-14. Review.

PMID:
26548029
11.

Canagliflozin Treatment in Patients with Type 2 Diabetes Mellitus.

Triplitt C, Cornell S.

Clin Med Insights Endocrinol Diabetes. 2015 Oct 18;8:73-81. doi: 10.4137/CMED.S31526. eCollection 2015. Review.

12.

Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus: U.S. Preventive Services Task Force Recommendation Statement.

Siu AL; U S Preventive Services Task Force.

Ann Intern Med. 2015 Dec 1;163(11):861-8. doi: 10.7326/M15-2345. Epub 2015 Oct 27.

PMID:
26501513
13.

Study of the effect of vitamin D supplementation on glycemic control in type 2 diabetic prevalent hemodialysis patients.

Ibrahim MA, Sarhan II, Halawa MR, Afify EN, Hebah HA, Al-Gohary EA, El-Shazly IO.

Hemodial Int. 2015 Oct;19 Suppl 3:S11-9. doi: 10.1111/hdi.12347.

PMID:
26448381
14.

Use of oral combination therapy for type 2 diabetes in primary care: Meeting individualized patient goals.

Lavernia F, Adkins SE, Shubrook JH.

Postgrad Med. 2015;127(8):808-17. doi: 10.1080/00325481.2015.1085293. Epub 2015 Oct 6. Review.

PMID:
26439384
15.

Differential effects of prandial and non-prandial GLP-1 receptor agonists in type 2 diabetes therapy.

Davidson JA.

Postgrad Med. 2015;127(8):827-41. doi: 10.1080/00325481.2015.1096743. Epub 2015 Oct 1. Review.

PMID:
26428031
16.

Status of basal-supported oral therapy in Chinese type 2 diabetic patients with inadequate glycemic control on oral anti-diabetic drugs.

Xu W, Qiu L, Luo S, Li M, Weng J, Guo X, Ji L.

Diabetes Metab Res Rev. 2015 Nov;31(8):796-802. doi: 10.1002/dmrr.2709. Epub 2015 Oct 16.

PMID:
26356031
17.

Inpatient Glycemic Protocol for Patients with Diabetes Undergoing Bariatric Surgery.

Machnica K, Pannain S, Schulwolf E, Bartfield J, Emanuele MA.

Obes Surg. 2015 Nov;25(11):2200-4. doi: 10.1007/s11695-015-1860-y.

PMID:
26341084
18.

[On "2015 Guidelines for Prevention and Treatment of Osteoporosis". Lifestyle-related disease associated osteoporosis: Diabetes].

Yamamoto M.

Clin Calcium. 2015 Sep;25(9):1319-27. doi: CliCa150913191327. Japanese.

PMID:
26320532
19.

Women with Type 2 Diabetes and Glycemic Control.

Gosse S.

Medsurg Nurs. 2014 Sep-Oct;23(5):317-20, 329.

PMID:
26292437
20.

Metabolic Syndrome: Insulin Resistance and Prediabetes.

Mayans L.

FP Essent. 2015 Aug;435:11-6. Review.

PMID:
26280340
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk